Key Market Indicators
The coverage of HIV/AIDS treatment in the Bahamas is expected to reach 79% of people living with HIV by 2026, up from 67% in 2021 – a growth of 2.5 points each year on average. Since 2005, the Bahamian market has increased by 6.9 points each year. In 2021, the Bahamas came in 70th place, with Colombia taking first place with 67%. Cape Verde, Latvia and Zimbabwe were second, third and fourth respectively. The prevalence of HIV/AIDS among people aged 0-14 in the Bahamas is expected to drop to 21 units in 2026, from 143 units in 2021 – a decrease of 29.9% each year on average. Since 1995, demand in the Bahamas has decreased by 22.2% each year. In 2021, the Bahamas placed 93rd, with Germany taking first place with 143 units. Nigeria, Mozambique and Tanzania were second, third and fourth respectively.
